Dr. Peter Weiden, MD
Psychiatry (Psychiatry Physician)
912 S Wood St, Uic Psychiatry Mc913
Chicago, IL 60612
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Psychiatry Physician primary
NY license 150916
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 12 companies reported 258 payments worth $236,649 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $70,257 |
|---|---|
| Alkermes, Inc. | $47,652 |
| Neurocrine Biosciences, Inc. | $40,188 |
| Luye Pharma (USA) LTD. | $27,190 |
| Vanda Pharmaceuticals Inc. | $20,493 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20,026 |
| Teva Pharmaceuticals USA, Inc. | $10,634 |
| Acadia Pharmaceuticals Inc | $63.67 |
| Consulting Fee | $114,502 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $75,920 |
| Travel and Lodging | $19,858 |
| Honoraria | $19,800 |
| Food and Beverage | $6,569 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Oct 20, 2025 | Consulting Fee | $12,674 |
| E.r. Squibb & Sons, L.l.c. Nov 25, 2025 | Consulting Fee | $10,540 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 11, 2025 | Consulting Fee | $9,630 |
| Neurocrine Biosciences, Inc. Apr 3, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $9,200 |
| E.r. Squibb & Sons, L.l.c. Dec 1, 2025 | Consulting Fee | $8,499 |
| Alkermes, Inc. Mar 25, 2025 | Consulting Fee LYBALVI; LYBALVI; LYBALVI · CNS | $8,080 |
| E.r. Squibb & Sons, L.l.c. Jun 17, 2025 | Consulting Fee | $7,742 |
| Alkermes, Inc. Apr 24, 2025 | Consulting Fee LYBALVI; LYBALVI; LYBALVI · CNS | $7,720 |
| Vanda Pharmaceuticals Inc. Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) FANAPT · SCHIZOPHRENIA | $7,020 |
| Teva Pharmaceuticals USA, Inc. Dec 19, 2025 | Consulting Fee | $6,885 |
All 145 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. Dec 19, 2025 | Consulting Fee | $6,885 |
| Alkermes, Inc. Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) LYBALVI; LYBALVI; LYBALVI · CNS | $2,720 |
| Alkermes, Inc. Dec 16, 2025 | Travel and Lodging LYBALVI; LYBALVI; LYBALVI · CNS · travel to NEW YORK, NY · in-kind | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 11, 2025 | Consulting Fee | $9,630 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 11, 2025 | Travel and Lodging travel to Colorado Springs, CO · in-kind | $140 |
| Alkermes, Inc. Dec 9, 2025 | Consulting Fee | $1,010 |
| Luye Pharma (USA) LTD. Dec 7, 2025 | Honoraria ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $2,400 |
| Luye Pharma (USA) LTD. Dec 7, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Westbury, NY · in-kind | $322 |
| Vanda Pharmaceuticals Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) FANAPT · SCHIZOPHRENIA | $3,120 |
| Vanda Pharmaceuticals Inc. Dec 4, 2025 | Travel and Lodging FANAPT · SCHIZOPHRENIA · travel to NEW YORK, NY | $80.42 |
| E.r. Squibb & Sons, L.l.c. Dec 1, 2025 | Consulting Fee | $8,499 |
| E.r. Squibb & Sons, L.l.c. Nov 25, 2025 | Consulting Fee | $10,540 |
| Luye Pharma (USA) LTD. Nov 21, 2025 | Consulting Fee ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $2,100 |
| Vanda Pharmaceuticals Inc. Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) FANAPT · SCHIZOPHRENIA | $1,560 |
| Teva Pharmaceuticals USA, Inc. Nov 10, 2025 | Consulting Fee | $1,572 |
| E.r. Squibb & Sons, L.l.c. Nov 5, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to DALLAS, TX | $215 |
| E.r. Squibb & Sons, L.l.c. Nov 4, 2025 | Travel and Lodging travel to Vienna, Austria · in-kind | $334 |
| Neurocrine Biosciences, Inc. Oct 30, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $176 |
| Luye Pharma (USA) LTD. Oct 23, 2025 | Honoraria ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $1,500 |
| Neurocrine Biosciences, Inc. Oct 22, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $3,738 |
| Neurocrine Biosciences, Inc. Oct 22, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to MOUNTAIN LAKES, NJ · in-kind | $814 |
| E.r. Squibb & Sons, L.l.c. Oct 20, 2025 | Consulting Fee | $12,674 |
| Vanda Pharmaceuticals Inc. Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) FANAPT · SCHIZOPHRENIA | $3,120 |
| Vanda Pharmaceuticals Inc. Oct 16, 2025 | Travel and Lodging FANAPT · SCHIZOPHRENIA · travel to BROOKLYN, NY | $27.68 |
| Neurocrine Biosciences, Inc. Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $3,738 |
| Neurocrine Biosciences, Inc. Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $3,738 |
| Neurocrine Biosciences, Inc. Oct 15, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to NEW YORK, NY · in-kind | $107 |
| Neurocrine Biosciences, Inc. Oct 15, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to NEW YORK, NY · in-kind | $62.48 |
| Neurocrine Biosciences, Inc. Oct 15, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to NEW YORK, NY · in-kind | $45.87 |
| Neurocrine Biosciences, Inc. Oct 15, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to NEW YORK, NY · in-kind | $8.83 |
| Vanda Pharmaceuticals Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) FANAPT · SCHIZOPHRENIA | $3,120 |
| E.r. Squibb & Sons, L.l.c. Oct 9, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Dallas, TX | $326 |
| E.r. Squibb & Sons, L.l.c. Oct 9, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Dallas, TX | $290 |
| E.r. Squibb & Sons, L.l.c. Oct 9, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Dallas, TX | $51.73 |
| Neurocrine Biosciences, Inc. Oct 4, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $223 |
| Neurocrine Biosciences, Inc. Oct 3, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $552 |
| Neurocrine Biosciences, Inc. Oct 3, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $223 |
| Neurocrine Biosciences, Inc. Oct 3, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $115 |
| Alkermes, Inc. Sep 30, 2025 | Consulting Fee | $2,045 |
| Luye Pharma (USA) LTD. Sep 11, 2025 | Honoraria ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $3,300 |
| Luye Pharma (USA) LTD. Sep 11, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Syracuse, NY · in-kind | $368 |
| Luye Pharma (USA) LTD. Sep 11, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Syracuse, NY · in-kind | $286 |
| Luye Pharma (USA) LTD. Sep 11, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Syracuse, NY · in-kind | $273 |
| E.r. Squibb & Sons, L.l.c. Sep 3, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $294 |
| E.r. Squibb & Sons, L.l.c. Sep 2, 2025 | Compensation for services other than consulting (speaking, faculty) COBENFY · Neuroscience | $3,456 |
| Alkermes, Inc. Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) LYBALVI; LYBALVI; LYBALVI · CNS | $3,630 |
| Luye Pharma (USA) LTD. Aug 26, 2025 | Honoraria ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $3,900 |
| Luye Pharma (USA) LTD. Aug 26, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Dayton, OH · in-kind | $546 |
| Luye Pharma (USA) LTD. Aug 26, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Dayton, OH · in-kind | $382 |
| Luye Pharma (USA) LTD. Aug 26, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Dayton, OH · in-kind | $245 |
| Luye Pharma (USA) LTD. Aug 26, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Dayton, OH · in-kind | $155 |
| Luye Pharma (USA) LTD. Aug 26, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Dayton, OH · in-kind | $5.00 |
| Luye Pharma (USA) LTD. Aug 21, 2025 | Honoraria ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $2,400 |
| Luye Pharma (USA) LTD. Aug 21, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Garden City, NY · in-kind | $320 |
| Alkermes, Inc. Aug 20, 2025 | Travel and Lodging LYBALVI; LYBALVI; LYBALVI · CNS · travel to NEW YORK, NY · in-kind | $124 |
| Vanda Pharmaceuticals Inc. Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) FANAPT · SCHIZOPHRENIA | $7,020 |
| Vanda Pharmaceuticals Inc. Aug 15, 2025 | Travel and Lodging FANAPT · SCHIZOPHRENIA · travel to MIAMI, FL | $782 |
| Vanda Pharmaceuticals Inc. Aug 15, 2025 | Travel and Lodging FANAPT · SCHIZOPHRENIA · travel to MIAMI, FL | $325 |
| Vanda Pharmaceuticals Inc. Aug 15, 2025 | Travel and Lodging FANAPT · SCHIZOPHRENIA · travel to MIAMI, FL | $219 |
| Vanda Pharmaceuticals Inc. Aug 15, 2025 | Travel and Lodging FANAPT · SCHIZOPHRENIA · travel to MIAMI, FL | $159 |
| Vanda Pharmaceuticals Inc. Aug 15, 2025 | Travel and Lodging FANAPT · SCHIZOPHRENIA · travel to MIAMI, FL | $90.30 |
| Vanda Pharmaceuticals Inc. Aug 15, 2025 | Travel and Lodging FANAPT · SCHIZOPHRENIA · travel to MIAMI, FL | $12.00 |
| Alkermes, Inc. Aug 13, 2025 | Consulting Fee LYBALVI; LYBALVI; LYBALVI · CNS | $1,130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Aug 12, 2025 | Consulting Fee | $890 |
| Luye Pharma (USA) LTD. Jul 16, 2025 | Honoraria ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $2,400 |
| Luye Pharma (USA) LTD. Jul 16, 2025 | Travel and Lodging ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults · travel to Pelham, NY · in-kind | $97.16 |
| E.r. Squibb & Sons, L.l.c. Jul 15, 2025 | Travel and Lodging travel to Dallas, TX · in-kind | $229 |
| Luye Pharma (USA) LTD. Jul 14, 2025 | Consulting Fee ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $1,650 |
| Alkermes, Inc. Jul 9, 2025 | Consulting Fee ARISTADA; ARISTADA; ARISTADA · CNS | $6,360 |
| Alkermes, Inc. Jul 2, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to Waltham, MA · in-kind | $169 |
| Neurocrine Biosciences, Inc. Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $3,738 |
| Neurocrine Biosciences, Inc. Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $3,738 |
| Neurocrine Biosciences, Inc. Jun 25, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to WEST ORANGE, NJ · in-kind | $51.80 |
| Neurocrine Biosciences, Inc. Jun 25, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to WEST ORANGE, NJ · in-kind | $23.06 |
| E.r. Squibb & Sons, L.l.c. Jun 17, 2025 | Consulting Fee | $7,742 |
| Alkermes, Inc. Jun 6, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to Waltham, MA · in-kind | $267 |
| Alkermes, Inc. Jun 6, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to Waltham, MA · in-kind | $264 |
| Neurocrine Biosciences, Inc. Jun 4, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $125 |
| Neurocrine Biosciences, Inc. Jun 4, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $105 |
| Neurocrine Biosciences, Inc. Jun 4, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $5.00 |
| Teva Pharmaceuticals USA, Inc. May 21, 2025 | Consulting Fee | $1,965 |
| Alkermes, Inc. May 13, 2025 | Consulting Fee | $4,295 |
| Alkermes, Inc. May 13, 2025 | Travel and Lodging travel to WALTHAM, MA · in-kind | $264 |
| Luye Pharma (USA) LTD. May 12, 2025 | Honoraria ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $2,100 |
| Alkermes, Inc. May 2, 2025 | Travel and Lodging LYBALVI; LYBALVI; LYBALVI · CNS · travel to Rosemont, IL · in-kind | $64.73 |
| Alkermes, Inc. May 2, 2025 | Travel and Lodging LYBALVI; LYBALVI; LYBALVI · CNS · travel to Rosemont, IL · in-kind | $59.88 |
| E.r. Squibb & Sons, L.l.c. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) COBENFY · Neuroscience | $2,419 |
| Alkermes, Inc. Apr 24, 2025 | Consulting Fee LYBALVI; LYBALVI; LYBALVI · CNS | $7,720 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 15, 2025 | Consulting Fee | $4,895 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 15, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 10, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $208 |
| E.r. Squibb & Sons, L.l.c. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) COBENFY · Neuroscience | $3,456 |
| E.r. Squibb & Sons, L.l.c. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) COBENFY · Neuroscience | $2,074 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 7, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $16.14 |
| Alkermes, Inc. Apr 5, 2025 | Travel and Lodging LYBALVI; LYBALVI; LYBALVI · CNS · travel to Rosemont, IL · in-kind | $238 |
| Alkermes, Inc. Apr 5, 2025 | Travel and Lodging LYBALVI; LYBALVI; LYBALVI · CNS · travel to Rosemont, IL · in-kind | $23.00 |
| Neurocrine Biosciences, Inc. Apr 3, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $9,200 |
| E.r. Squibb & Sons, L.l.c. Apr 2, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Evansville, IN | $160 |
| E.r. Squibb & Sons, L.l.c. Apr 2, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Staten Island, NY | $69.72 |
| E.r. Squibb & Sons, L.l.c. Apr 2, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Evansville, IN | $39.99 |
| E.r. Squibb & Sons, L.l.c. Apr 2, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Staten Island, NY | $32.08 |
| E.r. Squibb & Sons, L.l.c. Apr 2, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Evansville, IN | $5.00 |
| Alkermes, Inc. Apr 1, 2025 | Consulting Fee | $1,061 |
| Alkermes, Inc. Mar 25, 2025 | Consulting Fee LYBALVI; LYBALVI; LYBALVI · CNS | $8,080 |
| Alkermes, Inc. Mar 25, 2025 | Travel and Lodging LYBALVI; LYBALVI; LYBALVI · CNS · travel to DALLAS, TX · in-kind | $103 |
| E.r. Squibb & Sons, L.l.c. Mar 19, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Staten Island, NY | $180 |
| E.r. Squibb & Sons, L.l.c. Mar 19, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Staten Island, NY | $9.47 |
| E.r. Squibb & Sons, L.l.c. Mar 18, 2025 | Compensation for services other than consulting (speaking, faculty) COBENFY · Neuroscience | $6,222 |
| E.r. Squibb & Sons, L.l.c. Mar 18, 2025 | Compensation for services other than consulting (speaking, faculty) COBENFY · Neuroscience | $2,489 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 15, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 15, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $134 |
| Neurocrine Biosciences, Inc. Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $3,738 |
| Neurocrine Biosciences, Inc. Mar 11, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to SMITHTOWN, NY · in-kind | $68.60 |
| Neurocrine Biosciences, Inc. Mar 11, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to SMITHTOWN, NY · in-kind | $14.00 |
| Neurocrine Biosciences, Inc. Mar 8, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $243 |
| Neurocrine Biosciences, Inc. Mar 8, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $61.72 |
| Neurocrine Biosciences, Inc. Mar 7, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $2,238 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 7, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $258 |
| Neurocrine Biosciences, Inc. Mar 7, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 7, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $175 |
| Alkermes, Inc. Mar 4, 2025 | Consulting Fee | $1,010 |
| E.r. Squibb & Sons, L.l.c. Mar 3, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Evansville, IN | $1,454 |
| E.r. Squibb & Sons, L.l.c. Mar 3, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Evansville, IN | $568 |
| E.r. Squibb & Sons, L.l.c. Mar 3, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Evansville, IN | $340 |
| Alkermes, Inc. Feb 28, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to Washington, DC · in-kind | $216 |
| Alkermes, Inc. Feb 27, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to Washington, DC · in-kind | $173 |
| E.r. Squibb & Sons, L.l.c. Feb 14, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Saint Louis, MO | $258 |
| E.r. Squibb & Sons, L.l.c. Feb 14, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Saint Louis, MO | $134 |
| E.r. Squibb & Sons, L.l.c. Feb 14, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Washington, MO | $75.74 |
| E.r. Squibb & Sons, L.l.c. Feb 14, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Washington, MO | $35.00 |
| Neurocrine Biosciences, Inc. Feb 13, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $2,000 |
| E.r. Squibb & Sons, L.l.c. Feb 11, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Boston, MA | $386 |
| E.r. Squibb & Sons, L.l.c. Feb 11, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Saint Louis, MO | $30.58 |
| E.r. Squibb & Sons, L.l.c. Feb 11, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Chesterfield, MO | $18.80 |
| E.r. Squibb & Sons, L.l.c. Feb 11, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Boston, MA | $10.00 |
| Alkermes, Inc. Jan 29, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to Woburn, MA · in-kind | $239 |
| Alkermes, Inc. Jan 29, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to Fort Worth, TX · in-kind | $77.34 |
| Alkermes, Inc. Jan 28, 2025 | Consulting Fee | $657 |
| Alkermes, Inc. Jan 28, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to DALLAS, TX · in-kind | $304 |
| E.r. Squibb & Sons, L.l.c. Jan 21, 2025 | Travel and Lodging COBENFY · Neuroscience · travel to Staten Island, NY | $151 |
| E.r. Squibb & Sons, L.l.c. Jan 17, 2025 | Compensation for services other than consulting (speaking, faculty) COBENFY · Neuroscience | $3,456 |
| Luye Pharma (USA) LTD. Jan 16, 2025 | Honoraria ERZOFRI EXTENDED-RELEASE · Treatment of schizophrenia and schizoaffective disorder in adults | $1,800 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jan 14, 2025 | Consulting Fee | $2,893 |
| Alkermes, Inc. Jan 8, 2025 | Compensation for services other than consulting (speaking, faculty) ARISTADA; ARISTADA; ARISTADA · CNS | $3,630 |
| Alkermes, Inc. Jan 8, 2025 | Travel and Lodging ARISTADA; ARISTADA; ARISTADA · CNS · travel to NEW YORK, NY · in-kind | $122 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 8 industry-funded studies in 2025, from 4 companies. The companies reported $501,764 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
E.r. Squibb & Sons, L.l.c. - Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Vanda Pharmaceuticals Inc. - A multicenter, pragmatic study to evaluate clinical effectiveness and healthcare resource utilization of a digital therapeutic (CT-155) in patients with experiential negative symptoms of schizophrenia
Boehringer Ingelheim International GmbH - ITI-007-602
Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.) - A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania with Mixed Features in Bipolar-I Disorder
E.r. Squibb & Sons, L.l.c. - Randomized Withdrawal Study in Patients With Schizophrenia
Vanda Pharmaceuticals Inc. - A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
E.r. Squibb & Sons, L.l.c. · Recruiting · NCT06929273 - A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
E.r. Squibb & Sons, L.l.c. · Recruiting · NCT06951698
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.